ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Florida » Geriatric Medicine

Top Geriatric Medicine Prescribers in Florida

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
JACK GOLOFF D.O.

Geriatric Medicine

1,383

$130K

40
0 are 65+

93%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 25%

$94
Average prescription price

Avg: $54

EDUARDO DIAZ M.D.

Geriatric Medicine

1,883

$90K

63
59 are 65+

35%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 25%

$48
Average prescription price

Avg: $54

ANTHONY ALATRISTE MD

Geriatric Medicine

1,724

$83K

601
342 are 65+

22%
patients receiving schedule two controlled substances

Avg: 8%

20%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 25%

$48
Average prescription price

Avg: $54

MARIA-JOSEFINA RIVERA M.D.

Geriatric Medicine

23,334

$1.38M

716
417 are 65+

23%
patients receiving schedule two controlled substances

Avg: 8%

20%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 25%

$59
Average prescription price

Avg: $54

DAVID SAMARA MD

Geriatric Medicine

41,773

$2.55M

880
725 are 65+

13%
patients receiving schedule two controlled substances

Avg: 8%

25%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 25%

$61
Average prescription price

Avg: $54

JAMES JANOUSEK M.D.

Geriatric Medicine

38,045

$2.14M

899
678 are 65+

15%
patients receiving schedule two controlled substances

Avg: 8%

27%
patients receiving schedule three controlled substances

Avg: 9%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 25%

$56
Average prescription price

Avg: $54

SEGISMUNDO PARES M.D.

Geriatric Medicine

2,483

$93.8K

120
115 are 65+

23%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 9%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 25%

$38
Average prescription price

Avg: $54

EUGENE GRIFFIN MD

Geriatric Medicine

10,236

$555K

248
207 are 65+

15%
patients receiving schedule two controlled substances

Avg: 8%

25%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 25%

$54
Average prescription price

Avg: $54

HEATHER CAPPELLO M.D.

Geriatric Medicine

7,599

$292K

303
299 are 65+

23%
patients receiving schedule two controlled substances

Avg: 8%

10%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 25%

$38
Average prescription price

Avg: $54

JERRY ALSTOTT MD

Geriatric Medicine

12,140

$672K

197
180 are 65+

16%
patients receiving schedule two controlled substances

Avg: 8%

21%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 25%

$55
Average prescription price

Avg: $54

MARISOL SANCHEZ-LANCE MD

Geriatric Medicine

6,035

$353K

353
347 are 65+

11%
patients receiving schedule two controlled substances

Avg: 8%

12%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 25%

$59
Average prescription price

Avg: $54

GARY MILLER MD

Geriatric Medicine

1,376

$85.4K

83
66 are 65+

24%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 25%

$62
Average prescription price

Avg: $54

LINDA MORSE DO PLLC

Geriatric Medicine

7,832

$352K

226
190 are 65+

8%
patients receiving schedule two controlled substances

Avg: 8%

16%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 25%

$45
Average prescription price

Avg: $54

CLARA ROMAN M.D.

Geriatric Medicine

16,434

$876K

437
413 are 65+

10%
patients receiving schedule two controlled substances

Avg: 8%

18%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 25%

$53
Average prescription price

Avg: $54

INGRID ZUMARAN M.D.

Geriatric Medicine

53,586

$4.17M

968
592 are 65+

15%
patients receiving schedule two controlled substances

Avg: 8%

17%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 25%

$78
Average prescription price

Avg: $54

SCOTT RAY DO

Geriatric Medicine

24,050

$1.27M

755
670 are 65+

12%
patients receiving schedule two controlled substances

Avg: 8%

16%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$53
Average prescription price

Avg: $54

ISRAEL CARO M.D.

Geriatric Medicine

35,422

$1.1M

1045
798 are 65+

5%
patients receiving schedule two controlled substances

Avg: 8%

14%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

15%
prescriptions for brand name drugs

Avg: 25%

$31
Average prescription price

Avg: $54

KASHAN KHAN MD

Geriatric Medicine

8,773

$393K

539
405 are 65+

7%
patients receiving schedule two controlled substances

Avg: 8%

14%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 25%

$45
Average prescription price

Avg: $54

MOHAMMED ASIF M.D.

Geriatric Medicine

13,168

$751K

419
344 are 65+

11%
patients receiving schedule two controlled substances

Avg: 8%

15%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 25%

$57
Average prescription price

Avg: $54

BEHNAM BIRGANI DO

Geriatric Medicine

8,795

$496K

334
181 are 65+

12%
patients receiving schedule two controlled substances

Avg: 8%

20%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 25%

$56
Average prescription price

Avg: $54

INDUMATHI CHRISTOPHER MD

Geriatric Medicine

12,077

$902K

380
325 are 65+

9%
patients receiving schedule two controlled substances

Avg: 8%

18%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 25%

$75
Average prescription price

Avg: $54

ANGELICA JIMENEZ M.D.

Geriatric Medicine

655

$31.1K

80
46 are 65+

25%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 25%

$47
Average prescription price

Avg: $54

ANTHONY NICOSIA M.D.

Geriatric Medicine

5,306

$245K

157
155 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

11%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 25%

$46
Average prescription price

Avg: $54

SCOTT JUDD MD

Geriatric Medicine

28,889

$809K

1341
892 are 65+

5%
patients receiving schedule two controlled substances

Avg: 8%

15%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

14%
prescriptions for brand name drugs

Avg: 25%

$28
Average prescription price

Avg: $54

CHARLES MORGAN MD

Geriatric Medicine

26,545

$1.38M

653
574 are 65+

10%
patients receiving schedule two controlled substances

Avg: 8%

14%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 25%

$52
Average prescription price

Avg: $54

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank